# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-23-013675
Filing Date
2023-04-20
Accepted
2023-04-20 16:06:25
Documents
4
Period of Report
2023-06-08

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | hrtx_pre_14a_2023_for_fi.htm | PRE 14A | 1959777
2 | GRAPHIC | img97615051_0.jpg | GRAPHIC | 106572
3 | GRAPHIC | img97615051_1.jpg | GRAPHIC | 532217
4 | GRAPHIC | img97615051_2.jpg | GRAPHIC | 181610
| Complete submission text file | 0000950170-23-013675.txt |  | 3090397

Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33221 | Film No.: 23833160
SIC: 2834 Pharmaceutical Preparations